Journal Title:Nanomedicine
Medicine has developed throughout time but has remained forever concerned with the maintenance of health and thus the science of prevention and alleviation, and ultimately curing, of disease. To continue its development in new directions, medicine is now looking to nanomedicine, an emerging scientific specialty born from nanotechnology, which has grown up in the fields of engineering, physics, chemistry and biotechnology, and is now moving into medicine, with huge potential for expansion and development over the next decade and beyond.
As our knowledge of the human body continues to improve, nanotechnology will be developed to monitor, repair and control human biological systems at the molecular level. This will offer unique opportunities for developing new therapeutic approaches to diagnose, prevent, treat and eradicate life-threatening diseases and conditions (such as cancer and diabetes), as well as resolving pain and improving medical techniques (such as bone repair and surgical techniques), through various novel nanotechnological approaches.
Nanomedicine (ISSN 1743-5889) is a uniquely medicine-focused journal, addressing the important challenges and advances in medical nanoscale-structured material and devices, biotechnology devices and molecular machine systems and nanorobotics, delivering this essential information in concise, clear and attractive article formats. The journal is a valuable information source for all players in the field – academic, industrial and clinical researchers, pharmaceutical and biotechnology companies, regulatory authorities and others across the scientific community.
The nanomedicine field is still in its infancy, however, in the next few years there are likely to be further exciting developments across medical science, engineering, chemistry and physics. Diverse researchers working together under the nanomedicine umbrella will produce findings with potential medical uses: preventing, diagnosing and treating human diseases, as well as relieving pain. Nanomedicine will provide a critical overview of these advances as they unfold, helping to shape the future of medicine in this exciting era.
随着时间的推移,医学一直在发展,但始终关注维持健康,因此也是预防和减轻疾病并最终治愈疾病的科学。为了继续向新的方向发展,医学现在正在寻找纳米医学,这是一个从纳米技术中诞生的新兴科学专业,它在工程、物理、化学和生物技术领域成长起来,现在正在向医学方向发展,具有巨大的潜力。未来十年及以后的扩展和发展。
随着我们对人体的了解不断提高,纳米技术将被开发用于在分子水平上监测、修复和控制人体生物系统。这将为开发新的治疗方法来诊断、预防、治疗和根除危及生命的疾病和病症(如癌症和糖尿病)以及解决疼痛和改进医疗技术(如骨修复和手术技术)提供独特的机会, 通过各种新颖的纳米技术方法。
Nanomedicine (ISSN 1743-5889) 是一本以医学为重点的独特期刊,旨在解决医学纳米级结构材料和设备、生物技术设备和分子机器系统以及纳米机器人方面的重要挑战和进展,以简洁明了的方式提供这些重要信息和有吸引力的文章格式。该期刊是该领域所有参与者的宝贵信息来源——学术、工业和临床研究人员、制药和生物技术公司、监管机构以及整个科学界的其他人。
纳米医学领域仍处于起步阶段,但在未来几年内,医学科学、工程学、化学和物理学领域可能会出现更令人兴奋的发展。不同的研究人员在纳米医学的保护伞下合作,将产生具有潜在医学用途的发现:预防、诊断和治疗人类疾病,以及缓解疼痛。随着这些进展的展开,纳米医学将对这些进展进行批判性概述,有助于在这个激动人心的时代塑造医学的未来。
Nanomedicine创刊于2006年,由FUTURE MEDICINE LTD出版商出版,收稿方向涵盖医学 - 纳米科技全领域,此刊是中等级别的SCI期刊,所以过审相对来讲不是特别难,但是该刊专业认可度不错,仍然是一本值得选择的SCI期刊 。平均审稿速度约6.0个月,影响因子指数4.3,该期刊近期没有被列入国际期刊预警名单,广大学者值得一试。
大类学科 | 分区 | 小类学科 | 分区 | Top期刊 | 综述期刊 |
医学 | 3区 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY 生物工程与应用微生物 NANOSCIENCE & NANOTECHNOLOGY 纳米科技 | 3区 3区 | 是 | 是 |
名词解释:
中科院分区也叫中科院JCR分区,基础版分为13个大类学科,然后按照各类期刊影响因子分别将每个类别分为四个区,影响因子5%为1区,6%-20%为2区,21%-50%为3区,其余为4区。
WOS分区等级 | JCR所属学科 | 分区 |
Q1 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY NANOSCIENCE & NANOTECHNOLOGY | Q1 Q2 |
名词解释:
WOS即Web of Science,是全球获取学术信息的重要数据库,Web of Science包括自然科学、社会科学、艺术与人文领域的信息,来自全世界近9,000种最负盛名的高影响力研究期刊及12,000多种学术会议多学科内容。给期刊分区时会按照某一个学科领域划分,根据这一学科所有按照影响因子数值降序排名,然后平均分成4等份,期刊影响因子值高的就会在高分区中,最后的划分结果分别是Q1,Q2,Q3,Q4,Q1代表质量最高。
CiteScore | SJR | SNIP | CiteScore排名 | ||||||||||||||||||||||||
8.90 | 0.695 | 0.705 |
|
名词解释:
CiteScore:衡量期刊所发表文献的平均受引用次数。
SJR:SCImago 期刊等级衡量经过加权后的期刊受引用次数。引用次数的加权值由施引期刊的学科领域和声望 (SJR) 决定。
SNIP:每篇文章中来源出版物的标准化影响将实际受引用情况对照期刊所属学科领域中预期的受引用情况进行衡量。
是否OA开放访问: | h-index: | 年文章数: |
未开放 | 93 | 171 |
Gold OA文章占比: | 2021-2022最新影响因子(数据来源于搜索引擎): | 开源占比(OA被引用占比): |
10.47% | 5.5 | 0.09... |
研究类文章占比:文章 ÷(文章 + 综述) | 期刊收录: | 中科院《国际期刊预警名单(试行)》名单: |
65.17% | SCIE、SCI | 否 |
历年IF值(影响因子):
历年引文指标和发文量:
历年中科院JCR大类分区数据:
历年自引数据:
2019-2021国家/地区发文量统计:
国家/地区 | 数量 |
CHINA MAINLAND | 178 |
USA | 120 |
India | 78 |
Italy | 43 |
England | 32 |
Spain | 31 |
Egypt | 29 |
Iran | 26 |
Australia | 24 |
Brazil | 23 |
近年引用统计:
期刊名称 | 数量 |
BIOMATERIALS | 345 |
J CONTROL RELEASE | 338 |
ACS NANO | 212 |
INT J NANOMED | 203 |
INT J PHARMACEUT | 203 |
NANOMEDICINE-UK | 189 |
ACS APPL MATER INTER | 170 |
ADV DRUG DELIVER REV | 163 |
SCI REP-UK | 142 |
P NATL ACAD SCI USA | 133 |
近年被引用统计:
期刊名称 | 数量 |
INT J NANOMED | 208 |
NANOMEDICINE-UK | 189 |
PHARMACEUTICS | 159 |
J CONTROL RELEASE | 158 |
NANOMATERIALS-BASEL | 142 |
ACS APPL MATER INTER | 140 |
MAT SCI ENG C-MATER | 123 |
NANOSCALE | 112 |
ADV DRUG DELIVER REV | 107 |
INT J MOL SCI | 104 |
近年文章引用统计:
文章名称 | 数量 |
Nanopharmaceuticals and nanomedi... | 57 |
Magnetic iron oxide nanoparticle... | 30 |
Applications of cobalt ferrite n... | 24 |
Factors relating to the biodistr... | 24 |
Biocompatibility and toxicity of... | 24 |
The toxicity of silica nanoparti... | 23 |
Magnetic iron oxide nanoparticle... | 22 |
Freeze-dried and GMP-compliant p... | 22 |
Nanoparticle systems for cancer ... | 21 |
Recent progress in nanoscale met... | 20 |
同类学科的其他优质期刊 | 影响因子 | 中科院分区 |
Clinics In Chest Medicine | 2.667 | 3区 |
Jama Network Open | 5.032 | 1区 |
Postgraduate Medicine | 2.464 | 4区 |
Immunology Letters | 3.276 | 3区 |
Medicina-lithuania | 1.205 | 4区 |
International Journal Of Mental Health And Addiction | 1.648 | 4区 |
Chronic Respiratory Disease | 2.168 | 3区 |
Journal Of The Anatomical Society Of India | 0.227 | 4区 |
International Braz J Urol | 1.342 | 4区 |
Translational Behavioral Medicine | 2.864 | 3区 |
本站主要从事期刊咨询服务,不是任何杂志官网,不涉及任何出版事务、本站仅提供有限咨询服务,需要用户自己向出版商投搞且没有绿色通道,是否录用一切以出版商通知为准,本站提供的期刊信息均来源于国家新闻出版总署及网络,仅供参考,提及的第三方名称或商标,其知识产权均属于相应的出版商或期刊,本站与上述机构无从属关系,所有引用均出于解释服务内容的考量,符合商标法规范,本页信息均由法务团队进行把关,若期刊信息有任何问题,请联系我们,我们会认真核实处理。若用户需要出版服务,请联系出版商!
发表直通车,欢迎来到发表直通车
鲁ICP备2024070538号-2
鲁公网安备37152102000140